Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31
Published August 13, 2025 · Recall initiated: July 25, 2025
Summary
FDA records drug Class II recall D-0566-2025, published August 13, 2025 and initiated July 25, 2025. Recalling firm: Alembic Pharmaceuticals Limited; Status: Ongoing; Reported quantity: 9,492 bottles; Lot: Lot: 2305015142, Exp. Date: 9/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
What to do
Voluntary: Firm initiated
Get an email if DOXEPIN HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOXEPIN HYDROCHLORIDE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Distributor
- Nationwide in the USA.
- UPC
- 0362332645312
- Lot
- Lot: 2305015142, Exp. Date: 9/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDASemaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)August 13, 2025
- FDADuloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. ByAugust 13, 2025
- FDASemaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units onAugust 13, 2025
- FDADuloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle,August 13, 2025
- FDASemaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)August 13, 2025
- FDAXolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CAAugust 13, 2025
Questions about this recall
Was Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31 recalled?
Yes. FDA published recall D-0566-2025 on August 13, 2025. Reported hazard: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOXEPIN HYDROCHLORIDE. UPC: 0362332645312.